In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

22:20 EDT 13th October 2015 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,000+

Thursday 8th October 2015

Study: Pulmatrix's PUR1900 Inhaled Cystic Fibrosis Drug Demonstrates High Lung Retention and Potency Against Fungal Infection

LEXINGTON, Mass., Oct. 8, 2015 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM) today announced preclinical data showing that PUR1900 (iSPERSE™-formulated itraconazole), which is being developed as the first inhaled antifungal medication for cystic fibrosis, was active and potent in vitro against Aspergillus fumigatus, a pathogen causing pulmonary infection in cystic fibrosis, while achieving ...

Cerilliant Introduces Certified Spiking Solutions of Bile Acids

ST. LOUIS, Oct. 8, 2015 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that the Cerilliant® brand within its Applied Diagnostics and Testing business segment has launched its new bile acid reference standards product line with ten certified Snap-N-Spike® solutions of the most routinely tested bile acids and their stable-labeled internal standards. These new...

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer

Activation of oncogenes by mechanisms other than genetic aberrations such as mutations, translocations, or amplifications is largely undefined. Here we report a novel isoform of the anaplastic lymphoma kinase (ALK) that is expressed in ∼ 11% of mel...

More Comprehensive Training Materials Lead to Higher User Satisfaction with Blood Glucose Meters

WESTLAKE VILLAGE, Calif., Oct. 8, 2015 /PRNewswire/ -- Training materials that are accessible and easy to understand contribute to an overall increase in satisfaction among adults or parents of children with Type 1 or Type 2 diabetes who use a blood glucose meter, and satisfaction is significantly higher when they understand how to use their meter, according to the J.D. Power 2015 U.S. Blood Gluco...

Wednesday 7th October 2015

Report: Cardiology, in vitro diagnostics to lead medtech market

A new report from Evaluate MedTech charts out medical device performance through 2020 – and highlights in vitro diagnostics as a growth field.

Developing an Effective Global CDx Regulatory Strategy, Upcoming Webinar Presented by Precision for Medicine, Hosted by Xtalks

TORONTO, ON--(Marketwired - October 08, 2015) - In an upcoming webinar on October 19, 2015, Precision for Medicine experts will present strategies to develop and manage an effective Global Companion Diagnostic (CDx) Program, designed to maximize the chance of a successful, coordinated launch of a therapeutic and companion assay world-wide. Precision for Medicine experts Austin Speier, Director of...

World Market for Cancer Diagnostics, 2015 - Market Sizing and Opportunity Assessment

Dublin, Oct. 08, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( has announced the addition of the "The World Market for Cancer Diagnostics, 6th Edition" report to their offering. The World Market for

LED Medical Diagnostics Announces Warrant Extension

VANCOUVER, BC--(Marketwired - October 08, 2015) - LED Medical Diagnostics Inc. (“LED” or the “Company”) (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announced today that it is proposing a 12 month extension to the term of outstanding share purchase warrants (the “Warrants”) exercisable at a price of US$0.50 per common share for 14,661,989 common shares of LED, which were origin...

Nanosatellite testing at ANU

A European satellite mission has turned to The Australian National University (ANU) to help test science units for nanosatellites ahead of a mass launch next year. CubeSats — nanosatellites typically 10 cm3 — are emerging as a space industry standard design for low-cost space research. Originally conceived for student projects, more than 100 CubeSats have been launched around the Earth and ev...

Dengue NS3 protease

In vitro studies identified a

Histone deacetylase (HDAC); HDAC1

In vitro and mouse studies identified prodrug inhibitors of class I HDACs that could help treat cancer.

MAP kinase 1 (MAPK1; ERK-2)

In vitro and mouse studies identified an inhibitor of cytoplasmic

Myeloid-lymphoid or mixed-lineage leukemia (MLL; HRX); p53

In vitro and patient sample studies suggest inhibiting MLL could help treat p53-mutant cancers.

Nuclear receptor subfamily 2 group F member 2 (NR2F2; COUP-TFII)

In vitro and mouse studies suggest inhibiting

D&R: A new adipogenic cocktail that produces functional adipocytes from MSCs

(Society for Experimental Biology and Medicine) Multipotent mesechymal stromal cells (MSCs) have been recognized as a source of adipocytes both in vivo and in vitro. It is reported that, simultaneous activation of canonical signaling pathways by dexa...

Ambry Genetics Shows Expanded TP53 Testing Identifies More Carriers, Raising Questions About Clinical Definition of Li-Fraumeni Syndrome

Data from the largest cohort of individuals tested for TP53 mutations presented at ASHG 2015 Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, today announced new data affirming the effectiveness of

BioTime’s Subsidiary OncoCyte Corporation Files Form 10 Registration Statement for Planned Distribution

BioTime Plans Distribution of Shares of Subsidiary OncoCyte Corporation to BioTime Shareholders Planned Distribution to Allow OncoCyte Greater Access to Capital Markets as a Publicly Traded Company BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem c...

Adaptive Biotechnologies and Collaborators Demonstrate Value of Immunosequencing for Diagnosis of Cutaneous T-Cell Lymphoma

Adaptive Biotechnologies and collaborators at Brigham and Women’s Hospital today announced publication of a study demonstrating that the company’s revolutionary immunosequencing platform, which utilizes next-generation sequencing and advanced bioinformatics to sensitively profile all of the T cells in a biological sample, adds value in delivering more ...

bioAffinity Technologies Welcomes New Board Members

bioAffinity Technologies, a privately held cancer diagnostics company, will seat two new members on its Board of Directors at the third-quarter meeting Oct. 26, 2015. Company President and Chief Executive Officer Maria Zannes announced that Myron Holubiak and Barry Frankel are joining the Board. Holubiak previously served as President of Roche Lab...

New Research Identifies Leading Clinical CROs Best Positioned for Future Success

MENLO PARK, Calif., Oct. 7, 2015 /PRNewswire/ -- Life Science Strategy Group (LSSG) the leading strategic consulting firm to the CRO industry, is pleased to announce the results of a new 2015 study, Clinical CRO Future Industry Leadership & Performance Benchmarking, which focuses on clinical CRO operational performance, future industry leadership and direction.  The quantitative study sur...

FDA Clears the Focus Diagnostics Direct Test to Include 53 New Virus Strains for the 2015-2016 Flu Season

In advance of the 2015-2016 flu season, Focus Diagnostics, the products business of Quest Diagnostics, announced that its SimplexaT Flu A/B & RSV Direct Kit has received 510(k) clearance from the FDA for 46 additional influenza A and influ...

FDA Clears the Focus Diagnostics Direct Test to Include New Virus Strains for Flu Season

In advance of the 2015-2016 flu season, Focus Diagnostics, the products business of Quest Diagnostics, announced that its SimplexaT Flu A/B & RSV Direct Kit has received 510(k) clearance from the FDA for 46 additional influenza A and influ...

Influenza Vaccine Market 2015 Review and Influenza Diagnostic Testing Market Emerging Opportunities Analyzed in New Research Reports

PUNE, India, October 7, 2015 /PRNewswire/ -- adds Global Influenza Vaccine Market 2015 and 2015-2019 Emerging Opportunities in the Influenza Diagnostic Testing Market research reports to the pharmaceuticals and healthcare categories, respectively, of its library. Complete report on influenza vaccine market spread across 166 pages, profiling 14 major companies and supported wi...

Charles River Announces New and Continued Drug Discovery Collaborations

Wellcome Trust-Funded Projects Expand Partnerships with Charles River’s Global Discovery Services Business Charles River Laboratories International, Inc. (NYSE:

Agilent to supply genomic services to Angsana

Biospectrum The collaboration would enable Angsana to develop molecular diagnostics to create new solutions focused on fetal and maternal health [Read more]


News Quicklinks